• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孤立性心脏淀粉样变病例中的非侵入性诊断方法

Noninvasive Diagnostic Modalities in an Isolated Case of Cardiac Amyloidosis.

作者信息

Lewars Jennaire, Wazir Hersh, Gordon Brandon, Faluyi Uyi, Girgis Yousry

机构信息

Internal Medicine, Saint James School of Medicine, Chicago, USA.

Medicine, All Saints University College of Medicine, Toronto, CAN.

出版信息

Cureus. 2021 Apr 21;13(4):e14608. doi: 10.7759/cureus.14608.

DOI:10.7759/cureus.14608
PMID:34040908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8139363/
Abstract

Amyloidoses are a family of inherited or acquired disorders characterized by the deposition of insoluble extracellular protein fibrils in various organs and tissues, thereby impairing their function. Amyloidoses are typically misfolded proteins, and on rare occasions, can deposit in the myocardium resulting in an infiltrative/restrictive cardiomyopathy. Restrictive cardiomyopathy is an underdiagnosed cause of congestive heart failure (CHF) with preserved ejection fraction, atrial and ventricular arrhythmias along with conduction defects. In elderly patients, as with this study, cardiac amyloidosis most often results from abnormalities in the liver protein transthyretin (TTR), a thyroxine and retinol-retinol binding complex transporter in blood. Mutated serum TTR results in familial systemic amyloidosis, whereas wild-type TTR results in senile cardiac amyloidosis predominantly seen in elderly males. Scintigraphy, a common non-invasive method used to facilitate early diagnosis of cardiac amyloidosis was the method used in this study. However, the gold standard for definitive diagnosis of cardiac amyloidosis is endomyocardial biopsy (EMB). Besides organ transplant, which is rarely done, therapy for cardiac amyloidosis is mainly aimed at symptomatic and supportive care. Plenty of evidence has shown that the left ventricular ejection fraction (LVEF) in patients with restrictive cardiomyopathy is usually preserved. However, in this study, we review the unique case of an 82-year-old male who was diagnosed with isolated cardiac amyloidosis with severe systolic dysfunction (decreasedLVEF), the methods used to establish the diagnosis, as well as the therapeutic interventions.

摘要

淀粉样变性是一类遗传性或获得性疾病,其特征是不溶性细胞外蛋白原纤维沉积在各种器官和组织中,从而损害其功能。淀粉样变性通常是错误折叠的蛋白质,在极少数情况下,可沉积在心肌中,导致浸润性/限制性心肌病。限制性心肌病是射血分数保留的充血性心力衰竭(CHF)、房性和室性心律失常以及传导缺陷的一个未被充分诊断的原因。在老年患者中,如本研究中的患者,心脏淀粉样变性最常由肝脏蛋白转甲状腺素蛋白(TTR)异常引起,TTR是血液中的一种甲状腺素和视黄醇-视黄醇结合复合物转运蛋白。血清TTR突变导致家族性系统性淀粉样变性,而野生型TTR导致主要见于老年男性的老年性心脏淀粉样变性。闪烁扫描是一种用于促进心脏淀粉样变性早期诊断的常见非侵入性方法,本研究中使用的就是这种方法。然而,心脏淀粉样变性确诊的金标准是心内膜心肌活检(EMB)。除了很少进行的器官移植外,心脏淀粉样变性的治疗主要针对症状性和支持性护理。大量证据表明,限制性心肌病患者的左心室射血分数(LVEF)通常保留。然而,在本研究中,我们回顾了一例82岁男性被诊断为孤立性心脏淀粉样变性伴严重收缩功能障碍(LVEF降低)的独特病例、用于确诊的心内膜心肌活检(EMB)方法,以及治疗干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b263/8139363/84d37f079ce0/cureus-0013-00000014608-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b263/8139363/802864606863/cureus-0013-00000014608-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b263/8139363/0271239e3c22/cureus-0013-00000014608-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b263/8139363/cabb87c36802/cureus-0013-00000014608-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b263/8139363/cc8cd0775aea/cureus-0013-00000014608-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b263/8139363/bb47e0294cf6/cureus-0013-00000014608-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b263/8139363/84d37f079ce0/cureus-0013-00000014608-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b263/8139363/802864606863/cureus-0013-00000014608-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b263/8139363/0271239e3c22/cureus-0013-00000014608-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b263/8139363/cabb87c36802/cureus-0013-00000014608-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b263/8139363/cc8cd0775aea/cureus-0013-00000014608-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b263/8139363/bb47e0294cf6/cureus-0013-00000014608-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b263/8139363/84d37f079ce0/cureus-0013-00000014608-i06.jpg

相似文献

1
Noninvasive Diagnostic Modalities in an Isolated Case of Cardiac Amyloidosis.孤立性心脏淀粉样变病例中的非侵入性诊断方法
Cureus. 2021 Apr 21;13(4):e14608. doi: 10.7759/cureus.14608.
2
Transthyretin cardiac amyloidoses in older North Americans.北美老年人中的转甲状腺素蛋白心脏淀粉样变性。
J Am Geriatr Soc. 2012 Apr;60(4):765-74. doi: 10.1111/j.1532-5415.2011.03868.x. Epub 2012 Feb 13.
3
[Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].[形成原纤维的蛋白质:淀粉样变性。心脏病专家必须了解的一种疾病的新希望]
Ital Heart J Suppl. 2002 Jun;3(6):590-7.
4
Cardiac amyloidosis: An underdiagnosed/underappreciated disease.心脏淀粉样变性:一种被低估/认识不足的疾病。
Eur J Intern Med. 2019 Sep;67:1-13. doi: 10.1016/j.ejim.2019.07.022. Epub 2019 Jul 30.
5
Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction.转甲状腺素蛋白心脏淀粉样变性:发病机制、治疗方法以及在射血分数保留的心力衰竭中的新作用
Clin Med Insights Cardiol. 2015 Jan 5;8(Suppl 1):39-44. doi: 10.4137/CMC.S15719. eCollection 2014.
6
Wild type transthyretin cardiac amiloidozis as a rare and overlooked underlying etiology in a patient with heart failure with preserved ejection fraction and left ventricular hypertrophy.野生型转甲状腺素蛋白心脏淀粉样变性是射血分数保留的心力衰竭和左心室肥厚患者中一种罕见且易被忽视的潜在病因。
Turk Kardiyol Dern Ars. 2021 Oct;49(7):579-584. doi: 10.5543/tkda.2021.09310.
7
Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.心脏淀粉样变性:病理生理学、诊断和治疗的最新进展。
Trends Cardiovasc Med. 2018 Jan;28(1):10-21. doi: 10.1016/j.tcm.2017.07.004. Epub 2017 Jul 13.
8
Wild-Type Transthyretin Amyloidosis: A Prevalent and Underdiagnosed Cause of Heart Failure With Preserved Ejection Fraction.野生型转甲状腺素蛋白淀粉样变性:射血分数保留的心力衰竭的常见且诊断不足的病因。
Cureus. 2024 Jun 18;16(6):e62623. doi: 10.7759/cureus.62623. eCollection 2024 Jun.
9
Light-Chain (AL) Cardiac Amyloidosis Presenting as Heart Failure With Reduced Ejection Fraction.轻链型(AL)心脏淀粉样变性表现为射血分数降低的心力衰竭。
Cureus. 2024 Feb 29;16(2):e55271. doi: 10.7759/cureus.55271. eCollection 2024 Feb.
10
Amyloid transthyretin cardiac amyloidosis: diagnosis and management.淀粉样变甲状腺素运载蛋白型心脏淀粉样变性:诊断与管理
Expert Rev Cardiovasc Ther. 2019 Sep;17(9):673-681. doi: 10.1080/14779072.2019.1662723. Epub 2019 Sep 3.

引用本文的文献

1
Multimodality Imaging for Diagnosing Transthyretin Cardiac Amyloidosis.用于诊断转甲状腺素蛋白心脏淀粉样变的多模态成像
Cureus. 2023 Apr 19;15(4):e37838. doi: 10.7759/cureus.37838. eCollection 2023 Apr.
2
Inherited and Acquired Rhythm Disturbances in Sick Sinus Syndrome, Brugada Syndrome, and Atrial Fibrillation: Lessons from Preclinical Modeling.遗传性和获得性窦房结综合征、Brugada 综合征和心房颤动中的节律紊乱:临床前模型研究的启示。
Cells. 2021 Nov 15;10(11):3175. doi: 10.3390/cells10113175.

本文引用的文献

1
Case report: isolated cardiac amyloidosis: an enigma unravelled.病例报告:孤立性心脏淀粉样变性:谜团解开。
Methodist Debakey Cardiovasc J. 2015 Jan-Mar;11(1):53-8. doi: 10.14797/mdcj-11-1-53.
2
Transthyretin (TTR) cardiac amyloidosis.转甲状腺素蛋白(TTR)心脏淀粉样变性
Circulation. 2012 Sep 4;126(10):1286-300. doi: 10.1161/CIRCULATIONAHA.111.078915.
3
Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis.
二维斑点追踪超声心动图检测相对心尖纵向应变保留对于心脏淀粉样变性的诊断具有较高的敏感性和特异性。
Heart. 2012 Oct;98(19):1442-8. doi: 10.1136/heartjnl-2012-302353. Epub 2012 Aug 3.
4
Transthyretin-related amyloidoses and the heart: a clinical overview.转甲状腺素相关淀粉样变性病与心脏:临床概述。
Nat Rev Cardiol. 2010 Jul;7(7):398-408. doi: 10.1038/nrcardio.2010.67. Epub 2010 May 18.
5
Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens.通过激光显微切割和基于质谱的蛋白质组学分析对临床活检标本中的淀粉样变性进行分类。
Blood. 2009 Dec 3;114(24):4957-9. doi: 10.1182/blood-2009-07-230722. Epub 2009 Oct 1.